Found: 78
Select item for more details and to access through your institution.
Using prostate‐specific membrane antigen positron‐emission tomography to guide prostate biopsies and stage men at high‐risk of prostate cancer.
- Published in:
- BJU International, 2023, v. 132, n. 6, p. 705, doi. 10.1111/bju.16167
- By:
- Publication type:
- Article
Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer.
- Published in:
- BJU International, 2022, v. 129, n. 6, p. 768, doi. 10.1111/bju.15710
- By:
- Publication type:
- Article
Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging.
- Published in:
- BJU International, 2022, v. 129, n. 1, p. 54, doi. 10.1111/bju.15492
- By:
- Publication type:
- Article
Food‐effect study of nilotinib in chronic myeloid leukaemia (NiFo study): Enabling dose reduction and relief of treatment burden.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 148, doi. 10.1111/ejh.13418
- By:
- Publication type:
- Article
Needs for information and reasons for (non)adherence in chronic myeloid leukaemia: Be aware of social activities disturbing daily routines.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 5, p. 643, doi. 10.1111/ejh.13155
- By:
- Publication type:
- Article
Quantitative Parametric Perfusion Images Using <sup>15</sup>O-Labeled Water and a Clinical PET/CT Scanner: Test--Retest Variability in Lung Cancer.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 11, p. 1684, doi. 10.2967/jnumed.110.079137
- By:
- Publication type:
- Article
In Vivo Evaluation of P-Glycoprotein Modulation of 8 PET Radioligands Used Clinically.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 1, p. 81
- By:
- Publication type:
- Article
In Vivo Delineation of 5-HT<sub>1A</sub> Receptors in Human Brain with [<sup>18</sup>F]MPPF.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 11, p. 1830
- By:
- Publication type:
- Article
Carbon-11-Labeled Daunorubicin and Verapamil for Probing P-Glycoprotein in Tumors with PET.
- Published in:
- Journal of Nuclear Medicine, 1996, v. 37, n. 9, p. 1571
- By:
- Publication type:
- Article
A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 153, n. 2, p. 263, doi. 10.1007/s11060-021-03763-1
- By:
- Publication type:
- Article
Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
- Published in:
- Journal of Neuro-Oncology, 2019, v. 145, n. 1, p. 177, doi. 10.1007/s11060-019-03287-9
- By:
- Publication type:
- Article
Impact van de <sup>18</sup>F-DCFPyL PET/CT-scan op het behandeladvies voor patiënten met prostaatkanker en een biochemisch recidief na curatieve therapie.
- Published in:
- Tijdschrift voor Urologie, 2021, v. 11, n. 5, p. 89, doi. 10.1007/s13629-021-00330-1
- By:
- Publication type:
- Article
Tumorlokalisaties op PSMA-PET/CT bij patiënten met een persisterend meetbaar PSA na een radicale prostatectomie.
- Published in:
- Tijdschrift voor Urologie, 2021, v. 11, n. 4, p. 54, doi. 10.1007/s13629-021-00320-3
- By:
- Publication type:
- Article
177Lutetium PSMA-radioligandtherapie bij prostaatkanker.
- Published in:
- Tijdschrift voor Urologie, 2020, v. 10, n. 4, p. 60, doi. 10.1007/s13629-019-00275-6
- By:
- Publication type:
- Article
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 9, p. 1213, doi. 10.1007/s00228-020-02910-3
- By:
- Publication type:
- Article
Feasibility of and patients' perspective on nilotinib dried blood spot self-sampling.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 6, p. 825, doi. 10.1007/s00228-019-02640-1
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Phase I trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.255679
- By:
- Publication type:
- Article
Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.252528
- By:
- Publication type:
- Article
<sup>11</sup>C-sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for early evaluation of sorafenib therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.251611
- By:
- Publication type:
- Article
The navigating and de-risking role of <sup>89</sup>Zr-immuno-PET in the development of biopharmaceuticals.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.239558
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.252528
- By:
- Publication type:
- Article
<sup>11</sup>C-sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for early evaluation of sorafenib therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.251611
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [ <sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Repeatability of Quantitative<sup> 18</sup>F‐DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F‐DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F‐DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [ 18F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F‐DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F‐DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F‐DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 2, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article